Reflect Scientific awarded patent for low temperature bulk shipping system

Covid vaccine-capable system can transport products at a controlled temperature between +20°C and -90°C


Reflect Scientific, Inc. has been awarded a patent for a cryogenic modular shipping unit that can uniformly maintain its payload at temperatures as low as -90°C, making it suited for cold chain management of biologics including Covid-19 vaccines.

The cryogenic system provides a capability of short or long duration bulk shipping and may also be used for long-term storage.

Low-temperature shipping system for high-value vaccines and biologicals. (Image credit: Reflect Scientific, Inc.)

The commercially available Cryometrix S-90 shipping system eliminates managing loads of dry ice, waiting hours for the temperature to saturate the shipping container, and having little to no control over product temperature during shipping.

It bundles Reflect Scientific’s upright liquid nitrogen freezer technology with an onboard liquid nitrogen tank and power supply. The user can ship up to 33.5 cubic feet of product (or 70,000 vials) at a controlled temperature between +20°C down to -90°C with a uniformity of ± 3°C.

The S-90 features temperature and data logging that can be accessed through the touch screen or downloaded to a computer. Security issues are mitigated with three security levels and up to 30 users. It can control who opens the freezer, changes the temperature set-point and changes the settings.

Each Cryometrix shipping system is customizable to meet individual shipping needs, including for vaccines and biologics, whether used for cross country shipping at -90°C or for short trips, according to the company.

Reflect Scientific, based in Orem, UT, develops and markets proprietary technologies in cryogenic cooling for the biotechnology, pharmaceutical, medical and transportation markets.